本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Maravai LifeSciences Holdings, Inc.

2.67
-0.0600-2.20%
成交量:91.30万
成交额:245.06万
市值:3.84亿
市盈率:-2.31
高:2.77
开:2.71
低:2.63
收:2.73
数据加载中...
2024/10/29

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/09/12

重要事件披露

Form 8-K - Current report
2024/08/17

SEC问询函

Form CORRESP - Correspondence
2024/08/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/07

重要事件披露

Form 8-K - Current report
2024/07/29

重要事件披露

Form 8-K - Current report
2024/06/25

SEC问询函

Form CORRESP - Correspondence
2024/06/12

重要事件披露

Form 8-K - Current report
2024/06/10

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/05/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/28

重要事件披露

Form 8-K - Current report
2024/05/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/05/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/09

重要事件披露

Form 8-K - Current report
2024/02/29

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/28

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/22

重要事件披露

Form 8-K - Current report
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/08

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]